Glover Steve C
Insider CIK 1304406 · ONCY Director · PDSB Director · AMAM Director · ZVSA Chief Executive Officer, Director · AMAM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCY ONCOLYTICS BIOTECH INC | A Award deriv | 2026-06-01 | 2026-06-03 | 96,000 | — | $0 | 96,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2025-07-11 | 2025-07-15 | 136,900 | — | $0 | 136,900 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy deriv | 2025-02-28 | 2025-03-03 | 15,061 | — | $0 | 15,061 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy | 2025-02-28 | 2025-03-03 | 15,061 | $1.66 | $25.0K | 78,851 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 30,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 2,500 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 5,714 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 12,142 | — | $0 | 0 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award | 2023-06-07 | 2023-06-09 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2024-07-18 | 1,627 | — | $0 | 1,627 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-05-18 | 2023-05-26 | 210,000 | — | $0 | 210,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-05-18 | 2023-06-09 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 168,761 | — | $0 | 168,761 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 18 | — | $0 | 1,750 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 138,980 | — | $0 | 138,980 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 1,750 | — | $0 | 1,750 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 264,838 | — | $0 | 264,838 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 126,138 | — | $0 | 126,138 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 17,903 | — | $0 | 17,903 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 3,022 | — | $0 | 3,022 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 70,881 | — | $0 | 70,881 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 79,417 | — | $0 | 79,417 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award | 2022-12-12 | 2022-12-14 | 43,847 | — | $0 | 43,847 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award | 2022-12-12 | 2022-12-14 | 448,909 | — | $0 | 448,909 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award | 2022-12-12 | 2022-12-14 | 85,442 | — | $0 | 85,442 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award | 2022-12-12 | 2022-12-14 | 49,636 | — | $0 | 49,636 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy | 2021-06-15 | 2021-06-17 | 5,882 | $8.50 | $50.0K | 63,790 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award | 2020-02-14 | 2020-02-19 | 38,400 | $1.30 | $49.9K | 57,908 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |